Abstract
Human papillomavirus (HPV) is considered to be a major etiological factor but is not sufficient for the development of cervical cancer. Other host factors including altered tumor suppressor gene activities might contribute to the carcinogenic process. Fragile Histidine Triad (FHIT) has been shown to play a pivotal role in carcinogenesis. Therefore, we made an attempt to find out point mutation of FHIT gene in HPV mediated cervical cancer in Indian women. 112 cases of cervical carcinoma tissue biopsies and 38 cervical scrapes samples of normal cytology were employed for this study. Herein, we report a novel mutation identified at nucleotide position 655, at codon 98 from CAT → CGT with ultimate replacement of amino acid Histidine by Arginine in cervical cancer cases. Molecular modeling was performed to predict the effect of this mutation in disease pathology. We predict that this change, His to Arg substitution in substrate-binding domain may generate catalytically inactive protein with loss of tumor suppressor activity.
Similar content being viewed by others
References
Das BC, Hussain S, Nasare V, Bharadwaj M (2008) Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 26:2669–2679
Cohen J (2005) Public health. HPV’s peculiarities, from infection to disease. Science 308:619
Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Munoz N, Meijer CJ, Herrero R (2003) Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case control study. Int J Cancer 107:127–133
Kohaar I, Thakur N, Salhan S, Batra S, Singh V, Sharma A, Sodhani P, Das BC, Sarkar DP, Bharadwaj M (2007) TNFalpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 29:249–256
Kohaar I, Hussain S, Thakur N, Tiwari P, Nasare V, Batra S, Singh V, Bhambani S, Das BC, Sarkar DP, Bharadwaj M (2009) Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women. Hum Immunol 70:222–229
Lea JS, Ashfaq R, Muneer S, Burbee DG, Miller DS, Minna JD, Muller CY (2004) Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development. J Soc Gynecol Investig 11:329–337
Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW (1996) FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187–195
Neyaz MK, Kumar RS, Hussain S, Naqvi SH, Kohaar I, Thakur N, Kashyap V, Das BC, Husain SA, Bharadwaj M (2008) Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population. Biomarkers 13:597–606
Wistuba II, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, Ahmadian M, Nowak JA, Muller C, Minna JD, Gazdar AF (1997) Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 57:3154–3158
Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587–597
Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K, Croce CM (1996) The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85:17–26
Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Munoz N, Bosch FX, Shah K, Cho KR (1997) Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 57:4692–4698
Croce CM, Sozzi G, Huebner K (1999) Role of FHIT in human cancer. J Clin Oncol 17:1618–1624
Kannan K, Munirajan AK, Bhuvarahamurthy V, Mohanprasad BK, Shankar P, Tsuchida N, Shanmugam G (2000) FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncol 36:189–193
Lima CD, D’Amico KL, Naday I, Rosenbaum G, Westbrook EM, Hendrickson WA (1997) MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family. Structure 5:763–774
Pace HC, Garrison PN, Robinson AK, Barnes LD, Draganescu A, Rosler A, Blackburn GM, Siprashvili Z, Croce CM, Huebner K, Brenner C (1998) Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. Proc Natl Acad Sci U S A 95:5484–5489
Gopalkrishna V, Aggarwal N, Malhotra VL, Koranne RV, Mohan VP, Mittal A, Das BC (2000) Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Clin Microbiol Infect 6:88–93
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
Manos M, Lee K, Greer C, Waldman J, Kiviat N, Holmes K, Wheeler C (1990) Looking for human papillomavirus type 16 by PCR. Lancet 335:734
Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K (1997) Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 57:504–512
Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 86:2766–2770
Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC (2005) p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 218:69–79
Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126–2132
Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723
Laskowski RA, Moss DS, Thornton JM (1993) Main-chain bond lengths and bond angles in protein structures. J Mol Biol 231:1049–1067
Ramachandran GN, Sasisekharan V (1968) Conformation of polypeptides and proteins. Adv Protein Chem 23:283–438
Parkin DM, Bray F (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24(Suppl 3):S11–S25
Das BC, Gopalkrishna V, Das DK, Sharma JK, Singh V, Luthra UK (1993) Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women. Cancer 72:147–153
Iwasawa A, Nieminen P, Lehtinen M, Paavonen J (1996) Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer 77:2275–2279
Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, Robinson AK, Ingram SW, Croce CM, Ohta M, Huebner K (1996) Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′, 5′′′-P1, p3-triphosphate hydrolase. Biochemistry 35:11529–11535
Thiagalingam S, Lisitsyn NA, Hamaguchi M, Wigler MH, Willson JK, Markowitz SD, Leach FS, Kinzler KW, Vogelstein B (1996) Evaluation of the FHIT gene in colorectal cancers. Cancer Res 56:2936–2939
Mao L, Fan YH, Lotan R, Hong WK (1996) Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 56:5128–5131
Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M, Bennett WP, Harris CC (1997) FHIT mutations in human primary gastric cancer. Cancer Res 57:1435–1437
Yoshino K, Enomoto T, Nakamura T, Nakashima R, Wada H, Saitoh J, Noda K, Murata Y (1998) Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer 76:176–181
Yoshino K, Enomoto T, Nakamura T, Sun H, Ozaki K, Nakashima R, Wada H, Saitoh J, Watanabe Y, Noda K, Murata Y (2000) FHIT alterations in cancerous and non-cancerous cervical epithelium. Int J Cancer 85:6–13
Acknowledgments
The authors are thankful to Dr. Rajyashri Sharma, Department of Obstetrics and Gynecology, JNMC, Aligarh, for providing clinical samples. This study was done under core fund of ICPO (ICMR), Noida.
Author information
Authors and Affiliations
Corresponding author
Additional information
Md. Kausar Neyaz and Showket Hussain contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Neyaz, M.K., Hussain, S., Hassan, M.I. et al. Novel missense mutation in FHIT gene: interpreting the effect in HPV-mediated cervical cancer in Indian women. Mol Cell Biochem 335, 53–58 (2010). https://doi.org/10.1007/s11010-009-0240-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0240-0